Cardiovascular

RhythMedix, a leader in remote cardiac monitoring released a next-generation RhythmStar wearable device with built-in 4G cellular connectivity. The novel cardiac telemetry monitor is...

In its effort to fight against COVID-19, the Ordnance Factory Board (OFB) has come up with a two-bed tent with necessary medical facilities that...

India Medtronic Private Limited, a wholly owned subsidiary of Medtronic plc, a global leader in healthcare technology, announced the launch of Arctic Front™ Cardiac Cryoablation...

Edwards Lifesciences announced that the first patient has been treated, in the RESTORE clinical trial, which will evaluate the safety and effectiveness of the...

New integrated workflow improves valve sizing accuracy during aortic valve replacement procedures

COVID-19 has affected global economy in three main ways. Firstly, by directly affecting production and demand, secondly by creating supply chain and market disruption, and thirdly by its financial impact on firms and financial markets. The global cardiovascular market continues to see rapid innovation with new drugs and devices entering the market. - Presented by Gopal Anand

Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technology, announced that it has completed the acquisition of MedAlliance,...

BIOTRONIK announced FDA clearance and availability of the Vital Data Sensor, which identifies body temperature increases potentially associated with fever, in the new BIOMONITOR...

Blackford, the pioneering strategic imaging AI platform and solutions provider, announces a partnership with Ligence Medical AI Solutions to make Ligence Heart available on...

Menstrual blood cells are unique; they multiply rapidly and can differentiate into many types of stem cells demonstrating great promise for future use in clinical regenerative medical therapies. Menstrual blood stem cell banking is the process of banking of menstrual blood for the purpose of cell therapy. - Mrs. Hema K

With the successful execution of the first-in-human telerobotic intervention, we are now opening new avenues and this is going to change the global scenario of telerobotic interventions. Dr. Tejas M. Patel, Chairman and Chief Interventional Cardiologist, Apex Heart Institute, Ahmedabad

Inovise Medical announced the U.S. Food and Drug Administration (FDA) has granted a device designation for its AUDICOR heart failure management system. The system...

RenalGuard Therapy protects at-risk patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) from Acute Kidney Injury.

MicroPort Cardio Rhythm Management (CRM) announced the first recruitment for the Astral-4LV clinical trial to evaluate the safety and efficacy of Axone, a left...

With its continued commitment towards advance therapy adoption in intervention cardiology for treating Complex and High-risk Coronary Intervention (CHIP) patients, Boston Scientific has collaborated...

Cardio Flow, a private medical device firm focusing in minimally invasive peripheral artery disease (PAD) treatments, has received FDA 510(k) clearance for its FreedomFlow...

From the successful closure of a patent ductus arteriosus in 1938 and the Blalock- Taussig shunt, discovery and innovation have been the hallmarks of cardiac surgery.

The results of the largest prospective study of patients-at-risk of Sudden Cardiac Arrest (SCA) in emerging countries – IMPROVE SCA – has revealed that...

Modern cardiac surgery owes its existence to technology as all other fields of medicine. Cardiac surgery with its various surgeries requires artificial valves, fabric grafts, Heart-Lung machine and its components and disposables, along with various other technological innovations in the ICU and in anaesthesia for successful outcomes.

Medcura, Inc., a commercial-stage medical device company, published the results of a peer-reviewed clinical study at the University of Chicago in this month's Cardiovascular...